Paul Hudson, Sanofi CEO (Eric Piermont/AFP via Getty Images)

Sanofi con­tin­ues mR­NA push in wake of Covid vac­cine set­back, part­ner­ing with Chi­na tech gi­ant Baidu

Back in June, Sanofi un­veiled a big project to re­shape its R&D around the fu­ture of mR­NA, and fol­lowed that up Mon­day by tak­ing a step to­ward achiev­ing that goal.

The French drug­mak­er signed a deal with Chi­nese tech gi­ant Baidu to ac­cess its AI al­go­rithm for mR­NA-based ther­a­peu­tics, Baidu said Mon­day morn­ing. It’s for an undis­closed sum, but Baidu not­ed its plat­forms will be used to “con­tribute to the op­ti­miza­tion of mR­NA se­quences” in Sanofi’s drug de­vel­op­ment process­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Vice President

Alexandria Real Estate Equities

San Francisco, CA, USA